november 27, 2023 0 0 CELEX:62023TB0203: Case T-203/23: Order of the General Court of 25 September 2023 — Studiocanal v EUIPO — Leonine Distribution (ARTHAUS) (EU trade mark — Application for a declaration of invalidity — Withdrawal of the application for a declaration of invalidity — No need to adjudicate)
november 27, 2023 0 0 CELEX:62023TB0204: Case T-204/23: Order of the General Court of 25 September 2023 — Studiocanal v EUIPO — Leonine Distribution (ARTHAUS) (EU trade mark — Application for a declaration of invalidity — Withdrawal of the application for a declaration of invalidity — No need to adjudicate)
september 25, 2023 0 0 CELEX:62023TB0222: Case T-222/23 R: Order of the President of the General Court of 21 July 2023 — Arysta Lifescience v EFSA (Interim relief — Access to documents — Regulation (EC) No 1049/2001 — Documents related to the procedure for renewing the approval of an active substance — Documents originating from a third party — Decision to grant a third party access to the documents — Application for suspension of operation of a measure — Concept of ‘information relating to emissions into the environment’ — Regulation (EC) No 1367/2006 — Prima facie case — Urgency — Balancing of competing interests)
maj 06, 2024 0 16 CELEX:62023TB0224: Case T-224/23: Order of the General Court of 21 February 2024 – VY v Parliament
april 02, 2024 0 0 CELEX:62023TB0226(01): Case T-226/23: Order of the General Court of 7 February 2024 — Neuraxpharm Pharmaceuticals v Commission (Action for annulment — Medicinal products for human use — Marketing authorisation for the medicinal product Dimethyl fumarate Neuraxpharm — dimethyl fumarate — Letter of the Commission drawing conclusions from a judgment of the Court of Justice — Measure not actionable — Inadmissibility — Hypothetical acts — Manifest inadmissibility)
september 25, 2023 0 0 CELEX:62023TB0226: Case T-226/23 R: Order of the President of the General Court of 19 July 2023 — Neuraxpharm Pharmaceuticals v Commission (Interim relief — Medicinal products for human use — Marketing authorisation — Application for interim measures — Application for injunction — Lack of urgency)
april 02, 2024 0 0 CELEX:62023TB0227(01): Case T-227/23: Order of the General Court of 7 February 2024 — Mylan Ireland v Commission (Action for annulment — Medicinal products for human use — Marketing authorisation for the medicinal product Dimethyl fumarate Mylan — dimethyl fumarate — Letter of the Commission drawing conclusions from a judgment of the Court of Justice — Measure not actionable — Inadmissibility — Hypothetical acts — Manifest inadmissibility)
september 25, 2023 0 0 CELEX:62023TB0227: Case T-227/23 R: Order of the President of the General Court of 19 July 2023 — Mylan Ireland v Commission (Interim relief — Medicinal products for human use — Marketing authorisation — Application for interim measures — Application for injunction — Lack of urgency)
april 22, 2024 0 20 CELEX:62023TB0228(01): Case T-228/23: Order of the General Court of 7 February 2024 – Zaklady Farmaceutyczne Polpharma v Commission
september 25, 2023 0 0 CELEX:62023TB0228: Case T-228/23 R: Order of the President of the General Court of 19 July 2023 — Zaklady Farmaceutyczne Polpharma v Commission (Interim relief — Medicinal products for human use — Marketing authorisation — Application for interim measures — Application for injunction — Lack of urgency)